Work

Erratum to: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

Year: 2010

Type: erratum

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9502-7

Authors: Deborah A. Bradley, Stephanie Daignault, Charles J. Ryan, Robert S. DiPaola, Kathleen A. Cooney, David C. Smith, Eric Small, Paul Mathew, Mitchell E. Gross, Mark N. Stein, Alice Chen, Kenneth J. Pienta, June Escara-Wilke, Gerald Doyle, Mahmoud Al-Hawary, Evan T. Keller, Maha Hussain

Institutions: Duke University, University of Michigan, University of California, San Francisco, Rutgers Cancer Institute, Tufts University, Cedars-Sinai Medical Center, National Institutes of Health, Johnson & Johnson (United States), Michigan Medicine, U-M Rogel Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2597594489

Cites: 3

Cited by: 8

Related to: 10